155 related articles for article (PubMed ID: 36424903)
1. Molecular and immunohistochemical testing of bone tumours: review and update.
Kovacs SK; Manassaporn A; Nielsen GP; Hung YP
Histopathology; 2023 May; 82(6):794-811. PubMed ID: 36424903
[TBL] [Abstract][Full Text] [Related]
2. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
3. Pathology of primary malignant bone and cartilage tumours.
Rozeman LB; Cleton-Jansen AM; Hogendoorn PC
Int Orthop; 2006 Dec; 30(6):437-44. PubMed ID: 16944143
[TBL] [Abstract][Full Text] [Related]
4. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts.
Nissi R; Böhling T; Autio-Harmainen H
Acta Histochem; 2004; 106(2):111-21. PubMed ID: 15147632
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of five unusual cases of intraosseous myoepithelial carcinomas, mimicking conventional primary bone tumours, including EWSR1 rearrangement in one case.
Rekhi B; Joshi S; Panchwagh Y; Gulia A; Borges A; Bajpai J; Jambehekar NA; Pant V; Mandholkar M; Byregowda S; Puri A
APMIS; 2016 Apr; 124(4):278-90. PubMed ID: 26768122
[TBL] [Abstract][Full Text] [Related]
7. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
8. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
[TBL] [Abstract][Full Text] [Related]
9. Small round cell lesions of the bone: Diagnostic approach, differential diagnoses and impact on treatment.
Rekhi B; Mridha A; Kattoor J
Indian J Pathol Microbiol; 2019; 62(2):199-205. PubMed ID: 30971540
[TBL] [Abstract][Full Text] [Related]
10. FGF23 Expression Is a Promising Immunohistochemical Diagnostic Marker for Undifferentiated Pleomorphic Sarcoma of Bone (UPSb).
Al-Hassi HO; Ali NM; Cooke H; De Silva S; Brini AT; Babu P; Sumathi V; Morris MR; Niada S
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397231
[No Abstract] [Full Text] [Related]
11. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
12. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide Phosphoribosyl Transferase Is Increased in Osteosarcomas and Chondrosarcomas Compared to Benign Bone and Cartilage.
Meram AT; Alzubaidi Y; Cotelingam J; Ghali G; Lopez L; Coppola D; Shackelford R
Anticancer Res; 2019 Apr; 39(4):1761-1765. PubMed ID: 30952715
[TBL] [Abstract][Full Text] [Related]
14. Current trends in the diagnosis and treatment of malignant bone tumors.
Schajowicz F
Clin Orthop Relat Res; 1983 Nov; (180):220-52. PubMed ID: 6313271
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of bone tumours: diagnostic implications.
Puls F; Niblett AJ; Mangham DC
Histopathology; 2014 Mar; 64(4):461-76. PubMed ID: 24428620
[TBL] [Abstract][Full Text] [Related]
16. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.
Machado I; López Guerrero JA; Navarro S; Mayordomo E; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2013 Jun; 462(6):665-71. PubMed ID: 23681112
[TBL] [Abstract][Full Text] [Related]
18. Osteogenic and chondrogenic sarcomas of the jaws.
Batsakis JG
Ann Otol Rhinol Laryngol; 1987; 96(4):474-5. PubMed ID: 3476008
[TBL] [Abstract][Full Text] [Related]
19. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
20. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
